Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Common Equity (2023 - 2025)

Fractyl Health (GUTS) has disclosed Common Equity for 3 consecutive years, with -$3.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity fell 106.32% year-over-year to -$3.2 million, compared with a TTM value of -$3.2 million through Sep 2025, down 106.32%, and an annual FY2024 reading of $28.4 million, up 108.74% over the prior year.
  • Common Equity was -$3.2 million for Q3 2025 at Fractyl Health, up from -$18.2 million in the prior quarter.
  • Across five years, Common Equity topped out at $84.2 million in Q1 2024 and bottomed at -$325.1 million in Q4 2023.
  • Average Common Equity over 3 years is -$88.1 million, with a median of -$3.2 million recorded in 2025.
  • The sharpest move saw Common Equity surged 131.96% in 2024, then plummeted 125.74% in 2025.
  • Year by year, Common Equity stood at -$325.1 million in 2023, then surged by 108.74% to $28.4 million in 2024, then tumbled by 111.18% to -$3.2 million in 2025.
  • Business Quant data shows Common Equity for GUTS at -$3.2 million in Q3 2025, -$18.2 million in Q2 2025, and $6.4 million in Q1 2025.